{"id":55788,"date":"2023-04-13T15:06:17","date_gmt":"2023-04-13T13:06:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/"},"modified":"2023-04-13T15:06:17","modified_gmt":"2023-04-13T13:06:17","slug":"atec-to-report-first-quarter-2023-financial-results-on-may-4-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/","title":{"rendered":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023"},"content":{"rendered":"
\n

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT \/ 4:30 p.m. ET.<\/p>\n

<\/a><\/p>\n

\nWebcast<\/b><\/p>\n

\nTo access the live webcast, please visit the Investor Relations Section<\/a> of ATEC\u2019s Corporate Website.<\/p>\n

\nDial-in<\/b><\/p>\n

\nTo dial into the live webcast, please register at this link<\/a>. Access details will be shared via email.<\/p>\n

\nReplay<\/b><\/p>\n

\nA replay of the webcast will remain available through the Investor Relations Section<\/a> of ATEC\u2019s Corporate Website for twelve months. In addition, a dial-in replay will be available beginning two hours after the webcast\u2019s completion through May 11, 2023. Access the replay by dialing (800) 770-2030 and referencing conference ID number 97241.<\/p>\n

\nAbout ATEC<\/b><\/p>\n

\nATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC\u2019s Organic Innovation Machine\u2122 is focused on developing new approaches that integrate seamlessly with the Company\u2019s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC\u2019s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor\/Media Contact:<\/b>
Tina Jacobsen, CFA
\n
Investor Relations
\n
(760) 494-6790
\n
investorrelations@atecspine.com<\/a><\/p>\n

\nCompany Contact:<\/b>
J. Todd Koning
\n
Chief Financial Officer
\n
Alphatec Holdings, Inc.
\n
investorrelations@atecspine.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT \/ 4:30 p.m. ET. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55788","6":"format-standard","7":"category-industry"},"yoast_head":"\nATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT \/ 4:30 p.m. ET. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-13T13:06:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023\",\"datePublished\":\"2023-04-13T13:06:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005167\\\/en\\\/1762523\\\/21\\\/informed_logo_on_white.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/\",\"name\":\"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005167\\\/en\\\/1762523\\\/21\\\/informed_logo_on_white.jpg\",\"datePublished\":\"2023-04-13T13:06:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005167\\\/en\\\/1762523\\\/21\\\/informed_logo_on_white.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005167\\\/en\\\/1762523\\\/21\\\/informed_logo_on_white.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/","og_locale":"en_US","og_type":"article","og_title":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend","og_description":"CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT \/ 4:30 p.m. ET. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-13T13:06:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023","datePublished":"2023-04-13T13:06:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/"},"wordCount":269,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/","url":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/","name":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg","datePublished":"2023-04-13T13:06:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230413005167\/en\/1762523\/21\/informed_logo_on_white.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/atec-to-report-first-quarter-2023-financial-results-on-may-4-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATEC to Report First Quarter 2023 Financial Results on May 4, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55788"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55788\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}